Phototherapy

Phototherapy uses controlled exposure to ultraviolet light, most commonly narrowband UVB or PUVA, to slow abnormal skin cell growth and calm inflammation in chronic skin disorders. It is delivered in a specialized light cabinet or through a targeted handheld device and is typically administered several times a week over a course of months. The treatment dose is carefully calculated and gradually increased based on the patient's skin response to maximize benefit while minimizing burning. It remains one of the most effective non-drug treatments for extensive or resistant psoriasis and vitiligo.

Phototherapy is recommended for patients diagnosed with specific conditions where other approaches have been insufficient. Your Dermatology specialist will assess your suitability based on your diagnosis, health history, and treatment goals.

The typical duration is 2-3 sessions per week for 8-12 weeks. This may vary based on the complexity of your case and individual response to treatment.

Recovery typically takes There is no downtime between sessions, though moisturizing is recommended after each treatment to reduce dryness. Noticeable improvement is typically seen after fifteen to twenty sessions, and some patients continue periodic maintenance therapy for chronic, relapsing conditions.. Your care team will provide specific instructions based on your response and overall health.

Side effects vary by individual and are detailed in the section above. Your specialist will discuss all risks and benefits with you before treatment begins. Serious adverse effects are uncommon but are part of the informed consent process.

Phototherapy has a documented success rate of 70-80% significant improvement in chronic skin conditions at accredited facilities. Outcomes depend on disease stage, patient health, and adherence to the treatment plan and aftercare instructions.